Anti-CD47 targeting in pancreatic cancer could remodel tumor- infiltrating immune cells38 and enhance CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies39. The gene discussed is CD47; the disease is familial pancreatic carcinoma.